Vomaris Innovations

Vomaris Innovations is a commercial-stage medical device company with a unique bioelectric technology platform for antimicrobial wound care. Its flagship product, Procellera (also available OTC as PowerHeal), uses a patented matrix of microcell batteries to generate an electric field that targets bacterial biofilm and supports the body's healing process. The company addresses a significant unmet need in chronic and surgical wound management, with products marketed through prescription, over-the-counter channels, and via a partnership with Arthrex for orthopedic applications.

V.DOX Technology: A patented bioelectric platform using a matrix of moisture-activated microcell batteries (elemental silver and zinc) to generate a sustained, wireless electric field. It is designed to mimic the body's natural 'current of injury,' disrupting bacterial biofilm, providing broad-spectrum antimicrobial activity without antibiotics, and supporting cellular processes for faster wound healing.

Vomaris competes in the advanced wound care market against giants like 3M, Smith & Nephew, and ConvaTec, who offer silver, foam, collagen, and negative pressure wound therapy products. Its key differentiation is its bioelectric, non-antibiotic mechanism targeting biofilm, a claim few competitors can make. In the OTC segment, it competes with Band-Aid (Johnson & Johnson) and Neosporin, differentiating on technology rather than traditional barrier or antibiotic properties.